Clinical Trial Update: A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Baxdrostat in combination with dapagliflozin to slow progression of chronic kidney disease in patients with CKD and hypertension. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hypertension

Drugs mentioned

• Baxdrostat (Baxdrostat)
• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Kidney Disease and Hypertension | Phase 3 | Status: ACTIVE_NOT_RECRUITING